These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25595904)

  • 1. A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts.
    De Luca A; Rotili D; Carpanese D; Lenoci A; Calderan L; Scimeca M; Mai A; Bonanno E; Rosato A; Geroni C; Quintieri L; Caccuri AM
    Oncotarget; 2015 Feb; 6(6):4126-43. PubMed ID: 25595904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
    Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM
    Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.
    De Luca A; Carpanese D; Rapanotti MC; Viguria TM; Forgione MA; Rotili D; Fulci C; Iorio E; Quintieri L; Chimenti S; Bianchi L; Rosato A; Caccuri AM
    Oncotarget; 2017 Feb; 8(9):15520-15538. PubMed ID: 28107182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment.
    Di Paolo V; Fulci C; Rotili D; De Luca A; Tomassi S; Serra M; Scimeca M; Geroni C; Quintieri L; Caccuri AM
    Biochem Pharmacol; 2020 Aug; 178():114060. PubMed ID: 32473836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.
    Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM
    Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma Cells.
    Sciarretta F; Fulci C; Palumbo C; Rotili D; Tentori L; Graziani G; Caccuri AM
    Chemotherapy; 2019; 64(3):138-145. PubMed ID: 31639786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.
    Rotili D; De Luca A; Tarantino D; Pezzola S; Forgione M; Morozzo Della Rocca B; Falconi M; Mai A; Caccuri AM
    Eur J Med Chem; 2015 Jan; 89():156-71. PubMed ID: 25462236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysis.
    Di Paolo V; Fulci C; Rotili D; Sciarretta F; Lucidi A; Morozzo Della Rocca B; De Luca A; Rosato A; Quintieri L; Caccuri AM
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1131-1139. PubMed ID: 31169043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound.
    Sha HH; Wang Z; Dong SC; Hu TM; Liu SW; Zhang JY; Wu Y; Ma R; Wu JZ; Chen D; Feng JF
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29358310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma.
    Tentori L; Dorio AS; Mazzon E; Muzi A; Sau A; Cuzzocrea S; Vernole P; Federici G; Caccuri AM; Graziani G
    Eur J Cancer; 2011 May; 47(8):1219-30. PubMed ID: 21269821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proapoptotic activity of new glutathione S-transferase inhibitors.
    Turella P; Cerella C; Filomeni G; Bullo A; De Maria F; Ghibelli L; Ciriolo MR; Cianfriglia M; Mattei M; Federici G; Ricci G; Caccuri AM
    Cancer Res; 2005 May; 65(9):3751-61. PubMed ID: 15867371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.
    Yang H; Higgins B; Kolinsky K; Packman K; Go Z; Iyer R; Kolis S; Zhao S; Lee R; Grippo JF; Schostack K; Simcox ME; Heimbrook D; Bollag G; Su F
    Cancer Res; 2010 Jul; 70(13):5518-27. PubMed ID: 20551065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrobenzoxadiazole-based GSTP1-1 inhibitors containing the full peptidyl moiety of (pseudo)glutathione.
    Luisi G; Mollica A; Carradori S; Lenoci A; De Luca A; Caccuri AM
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):924-30. PubMed ID: 26329912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability.
    Fulci C; Rotili D; De Luca A; Stella L; Morozzo Della Rocca B; Forgione M; Di Paolo V; Mai A; Falconi M; Quintieri L; Caccuri AM
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):240-247. PubMed ID: 28097896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase P1-1 as a target for mesothelioma treatment.
    De Luca A; Pellizzari Tregno F; Sau A; Pastore A; Palumbo C; Alama A; Cicconi R; Federici G; Caccuri AM
    Cancer Sci; 2013 Feb; 104(2):223-30. PubMed ID: 23121163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
    Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
    Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity.
    Liu Q; Liu Z; Hua W; Gou S
    J Med Chem; 2021 Feb; 64(3):1701-1712. PubMed ID: 33529017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation.
    Yang X; Liu G; Li H; Zhang Y; Song D; Li C; Wang R; Liu B; Liang W; Jing Y; Zhao G
    J Med Chem; 2010 Feb; 53(3):1015-22. PubMed ID: 20055416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest.
    Zhang P; Chen JH; Dong X; Tang MT; Gao LY; Zhao GS; Yu LG; Guo XL
    Biomed Pharmacother; 2013 Feb; 67(1):58-65. PubMed ID: 23201007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.